ANI Pharmaceuticals
ANIP
ANIP
123 hedge funds and large institutions have $402M invested in ANI Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 56 increasing their positions, 33 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $434M → $402M (-$32.1M)
13% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 24
Holders
123
Holding in Top 10
3
Calls
$16.9M
Puts
$5.64M
Top Buyers
| 1 | +$7.76M | |
| 2 | +$4.48M | |
| 3 | +$3.45M | |
| 4 |
TAM
Third Avenue Management
New York
|
+$3.21M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.81M |
Top Sellers
| 1 | -$13.1M | |
| 2 | -$11.5M | |
| 3 | -$9.66M | |
| 4 |
Millennium Management
New York
|
-$5.88M |
| 5 |
CCM
Consonance Capital Management
New York
|
-$4.27M |